OBIO icon

Orchestra BioMed
OBIO

Overview Fund Trends Analyst Outlook Journalist POV

23 hedge funds and large institutions have $56.4M invested in Orchestra BioMed in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

91% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 43

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$9.9M
2
+$3.89M
3
+$240K
4
Deutsche Bank
Deutsche Bank
Germany
+$149K
5
UBS Group
UBS Group
Switzerland
+$23.1K

Top Sellers

1
-$9.35M
2
-$7.97M
3
-$7.34M
4
AC
Amitell Capital
Singapore
-$5.98M
5
SC
Sculptor Capital
New York
-$5.41M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3